Aleafia Health Launches International Medical Cannabis White Label Services
28 nov. 2019 07h00 HE
|
Aleafia Health Inc.
TORONTO, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed production of its first white label production run...
Aleafia Health Reports First Profitable Third Quarter
12 nov. 2019 07h00 HE
|
Aleafia Health Inc.
Ultra low-cost production at $0.08 cost per gram at outdoor facilityAverage net revenue per gram equivalent of $15.11 for medical cannabis salesMedical cannabis sales up 43% Q/Q, adult-use cannabis...
Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram
11 nov. 2019 07h00 HE
|
Aleafia Health Inc.
Cannabinoid content per gram only slightly lower than identical strains grown indoorsCritical quality control tests successfulApproximately 1,000 kg yield per acre in Zone 1Expanded 3.7M sq. ft....
Aleafia Health to Announce 2019 Third Quarter Financial Results
23 oct. 2019 07h00 HE
|
Aleafia Health Inc.
TORONTO, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 Third Quarter Financial Results on November 12, 2019...
Aleafia Health Provides Guidance for Profitable Third Quarter 2019
24 sept. 2019 07h00 HE
|
Aleafia Health Inc.
Company maintains strong balance sheet with $51 million in cash on handConstruction of Paris Phase II Processing facility expected to be completed in October 2019Active, registered patients increased...
CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus
03 sept. 2019 08h20 HE
|
CB2 Insights
Company recruits prominent Colombian naturopathic and integrative medicine physician Dr. Paola Cubillos, MD, ND to lead medical cannabis research programs to advance emerging marketRapid growth in...
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
28 août 2019 16h05 HE
|
CB2 Insights
TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company focused on mainstreaming medical cannabis to the healthcare...
CB2 Insights Adds Former Johnson & Johnson Executive as Director
31 juil. 2019 08h00 HE
|
CB2 Insights
TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations
09 juil. 2019 07h30 HE
|
CB2 Insights
TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
Canna Care Docs Unveils New Website and Visual Identity
23 mai 2019 07h30 HE
|
Canna Care Docs
FALL RIVER, Mass., May 23, 2019 (GLOBE NEWSWIRE) -- Canna Care Docs, the largest and longest-running US-based medical clinic group specializing in cannabis evaluations and patient education, today...